Renal cell cancer: is there long-term survival advantage from cytokine treatment?
Oliver
R T
RT
Department of Medical Oncology, Medical College, Royal London Hospital.
D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000628:therapy*; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000628:therapy*; D009362:Neoplasm Metastasis; D009365:Neoplasm Regression, Spontaneous; D009392:Nephrectomy; D010865:Pilot Projects; D011379:Prognosis; D015996:Survival Rate
D016898:Interferon-alpha; D007376:Interleukin-2; D005472:Fluorouracil